Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | RAB9A | P51151 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 2/20 | 0.46 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | CES2 | O00748 | 1/20 | 0.42 |
| ▸ | CES1 | P23141 | 1/20 | 0.42 |
| ▸ | CTSL | P07711 | 2/20 | 0.42 |
| ▸ | CTSB | P07858 | 1/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.41 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1753793 | 0.76 | IDO1 (0.52) | RAB9AGAACES2CES1CTSL | |
| SCHEMBL17674229 | 0.76 | OGG1 (0.56) | ALDH1A1SMN1; SMN2MAPTGAALMNA | |
| SCHEMBL1753791 | 0.76 | MAPT (0.56) | NPC1HPGDRAB9AALDH1A1MAPT | |
| SCHEMBL10428909 | 0.76 | IDO1 (0.56) | NPC1HPGDRAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL4984479 | 0.76 | HDAC1 (0.48) | NPC1RAB9AALDH1A1MAPTLMNA | |
| SCHEMBL4200333 | 0.76 | CA1 (0.60) | NPC1HPGDRAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL442250 | 0.75 | POLB (0.50) | NPC1HPGDRAB9AALDH1A1SMN1; SMN2 | |
| Hydrochloric Acid SCHEMBL2108579 | 0.74 | IDO1 (0.50) | RAB9AGAACES2CES1CTSL | |
| SCHEMBL25234873 | 0.74 | NPC1 (0.47) | NPC1HPGDRAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL5147645 | 0.74 | PARP1 (0.52) | NPC1HPGDRAB9AALDH1A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-120112053-A | Inverted perovskite solar cell and preparation method thereof | 陕西师范大学 | 2025-06-06 | — | — | CN | disclosed |
| EP-2032584-A2 | THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF | Wyeth (US) | 2009-03-11 | — | — | EP | disclosed |
| US-20080125469-A1 | Thiadiazole compounds and methods of use thereof | WYETH (US) | 2008-05-29 | — | — | US | disclosed |
| WO-2007146138-A2 | THIADIAZOLE COMPOUNDS AND METHODS OF USE THEREOF | WYETH (US) | 2007-12-21 | — | — | WO | disclosed |
| WO-2005092304-A2 | ANTIFUNGAL AGENTS | F2G LTD (GB) | 2005-10-06 | — | — | WO | disclosed |
| EP-0123378-B1 | 1-NORMONYL DERIVATIVES, PROCESSES AND USE | BEECHAM GROUP PLC (GB) | 1989-09-06 | — | — | EP | disclosed |
| US-4861788-A | FUNGICIDE, BACTERICIDE | BEECHAM GROUP PLC (GB) | 1989-08-29 | — | — | US | disclosed |
| EP-0123378-A2 | 1-Normonyl derivatives, processes and use | BEECHAM GROUP PLC (GB) | 1984-10-31 | — | — | EP | disclosed |
| US-4309422-A | INSECTICIDES | VELSICOL CHEMICAL CORPORATION (US) | 1982-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080125469-A1 | Thiadiazole compounds and methods of use thereof | ADAMTS5, ADAMTS1, TIMP3 | NPC1 3469/4885HPGD 86/4885RAB9A 2706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.